Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 742180Generated: October 27, 2026

Dichloromethane → Flurithromycin

https://huagongshe.com/reaction/742180

Reaction equation

Participants

RoleNameHCIDCharge
ReactantDichloromethaneHCID 6344—
ReactantSodium HydroxideHCID 14798—
ReactantN-FluorobenzenesulfonimideHCID 588007—
Reactant(1S,2R,3R,4R,5R,8R,9S,10S,11R,12R,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-5-ethyl-3-hydroxy-9-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-2,4,8,10,12,14-hexamethyl-6,15,16-trioxatricyclo[10.2.1.11,4]hexadecan-7-oneHCID 21680609—
SolventAcetic AcidHCID 176—
SolventWaterHCID 962—
ProductFlurithromycinHCID 71260—

Reaction Steps

Anhydroerythromycin A (1 g, 1.4 mmole) was dissolved in glacial acetic acid (4-mL) at room temperature and the pH of the mixture was adjusted to 4.3 with 6N sodium hydroxide (approx. 2.5 mL) while the temperature was maintained below 20° C. N-fluorobenzenesulfonimide (0.44 g, 1.4 mmole) was added and stirring continued for an additional 18 hours at 22° C. Methylene chloride (10 mL) was added, the solution placed in an ice bath while the pH of the mixture was adjusted to 9 with 6N sodium hydroxide (approx. 17 mL) and the temperature maintained below 20° C. Next, water (10 mL) was added, the layers separated and the aqueous layer washed an additional two times with methylene chloride (10 mL each). The combined organic phases were washed 2 to 4 times with 5% sodium hydroxide (10 mL each) and dried over magnesium sulfate. After filtration, the organic phase was concentrated under vacuum at room temperature to afford 0.88 g of crude flurithromycin. The crude material was dissolved in ethanol concentrated to 2 mL. This process was repeated two more times. After standing at 0° C. for one night, the product was filtered under vacuum, washed with 0.5 mL cold ethanol and dried under vacuum at 40° C. to afford 0.53 g (51% yield) of flurithromycin.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS05552533
Source datasetuspto-grants-1996_09
ORD IDord-b6292bf4af034962bff5cf194b5e31a6
Source noteuspto-grants-1996_09